-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.00358.72% Upside
Immunic, Inc. Frequently Asked Questions
-
What analysts cover Immunic, Inc.?
Immunic, Inc. has been rated by research analysts at Leerink Partners in the past 90 days.